Augur Signals: News Feed

Latest Investment Activity Reports

Augur Signals: News Feed
Alert , Asset Management , Financial Services

The New Germany Fund, Inc.: Saba Capital Management, L.P. Buys $18,425 in Shares

  • Acquired: Non-Derivative
The New Germany Fund, Inc.: Saba Capital Management, L.P. Buys $18,425 in Shares
On October 29, 2025, Saba Capital Management, L.P. executed a transaction worth $18,425 in The New Germany Fund, Inc., reported on October 30, 2025. This increased their holdings by 0.084% to 1,966,833 shares. The fund's P/E ratio of 1.83 suggests undervaluation. Despite a recent price of $11.12, below the 5-day SMA of $11.23, a short-term target of $11.30 is possible. The insider's average ROI is 14.53%, indicating potential gains, though caution is advised due to negative MACD signals.
Alert , Technology , Electronic Components

Celestica Inc.: Laurette T Koellner Buys $2.02M Worth of Shares

  • Acquired: Non-Derivative
Celestica Inc.: Laurette T Koellner Buys $2.02M Worth of Shares
Koellner Laurette T, a Director and 10%+ Owner of Celestica Inc., purchased shares worth $2.02 million, increasing her confidence in the company's future. With a career average ROI of 40.92%, she has been with Celestica Inc. since 2002. The company shows a premium valuation with high P/E ratios and strong market interest. Despite positive insider activity and bullish indicators, high valuation metrics and overbought conditions suggest caution. The predicted price is $345.5 in 5 days, possibly consolidating to $340.0 in 4 weeks.
Alert , Asset Management , Financial Services

Ellsworth Growth and Income Fund Ltd.: Saba Capital Management, L.P. Invests $142,961

  • Acquired: Non-Derivative
Ellsworth Growth and Income Fund Ltd.: Saba Capital Management, L.P. Invests $142,961
On October 28, 2025, Saba Capital Management, L.P., a significant stakeholder in Ellsworth Growth and Income Fund Ltd., invested $142,961, boosting their ownership to 1,646,856 shares. Ellsworth Growth and Income Fund Ltd., with a P/E ratio of 6.55, is potentially undervalued compared to its peers. The stock's recent upward trend aligns with the NASDAQ, showing strong market correlation. Bullish indicators suggest a price rise to $12.50, despite potential risks of a pullback to $12.10. The predicted price in 5 days is $12.50, and in 4 weeks, $12.30.
Healthcare , Alert , Biotechnology

MapLight Therapeutics: Novo Holdings Buys $15.96M in Stock

  • Acquired: Non-Derivative
MapLight Therapeutics: Novo Holdings Buys $15.96M in Stock
On October 28, 2025, Novo Holdings A/S purchased stock in MapLight Therapeutics, Inc. valued at $15.96M. This increased their stake by 34.86%, now holding 3,686,622 shares. Despite negative valuation ratios and recent declines, this move signals potential recovery, supported by Novo Holdings's historical success and confidence. The stock, traded on NGM under MPLT, shows independent trading behavior, with short-term volatility likely, but potential stabilization in the mid-term.
Alert , Financial Services , Banks - Regional

Catalyst Bancorp, Inc.: Kleiser Kirk E. Executes a $63.7k Transaction

  • Acquired: Non-Derivative
On October 28, 2025, Kleiser Kirk E., a Director and major owner of Catalyst Bancorp, Inc., conducted a transaction worth $63.7k. This increased his holdings by 36.54%. Known for outperforming the market, his trades average a 14.35% ROI. Catalyst Bancorp's high P/E ratio of 23.14 suggests overvaluation, despite increased trading volume and bullish RSI levels. The stock's short-term price is predicted at $13.8, with potential stabilization at $13.5. The transaction was on the NCM exchange, ticker CLST.

Pages total: 1124

Calendar